General Medicine Raises $120M Series B to Build a Healthcare Store
Andreessen Horowitz led General Medicine's $120 million Series B as the company expands a nationwide catalog for medications, labs, telehealth and specialist care.
General Medicine has raised $120 million in Series B financing led by Andreessen Horowitz, with participation from Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup. The round brings total funding to $152 million.
What General Medicine is building
The company describes itself as a nationwide healthcare store. Its catalog includes more than 2,900 products and services across medications, laboratory tests, telehealth, specialist e-consults and selected in-person visits and procedures.
The product thesis is straightforward: let people search and compare care in a format closer to ecommerce, including upfront prices with and without insurance.
Why the round stands out
A $120 million Series B is large for a healthcare marketplace. The capital reflects the difficulty of building a national healthcare transaction layer: provider networks, pricing, insurance workflows, clinical operations and compliance all have to work together.
The key question is whether General Medicine can become a repeat purchasing layer rather than a collection of one-off healthcare transactions. Evidence to watch includes repeat usage, breadth of covered services, provider economics and whether transparent pricing actually changes how consumers shop for care.
Follow Venture Capital Tracker in Google
Add VCT as a preferred source to make our venture-capital coverage easier to find in Google Search.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
